Netherlands· NL-193b13e1211b

Olopatadine Brown & Burk 1 mg/ml oogdruppels, oplossing

A olopatadine product containing olopatadinehydrochloride, registered in Netherlands by Brown & Burk IR Limited. The same ATC class is registered in 13 of our 19 countries.

ATC S01GX09

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about olopatadinehydrochlorideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Olopatadine is registered in 13 of 19 countries.

Countries holding a registration under ATC S01GX09 (olopatadine), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
8 of them publish a price we can compare per daily dose

Search olopatadine products by name

Olopatadine · ATC S01GX09

13 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)

Active substance: OLOPATADINEHYDROCHLORIDE
Manufacturer: Brown & Burk IR Limited
Country: Netherlands (NL)
ATC code: S01GX09
ATC class: Olopatadine
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
129960

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

142 interactions on record for olopatadine.

Graded by severity as the source publishes them — 142 info. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check olopatadine against other medicines How interaction checks work

Olopatadine · interactions on record

142 records

142 info

Most severe, free to view

Mechanism and what to do, in the interaction check

Interaction register. Grades as the source publishes them.

Same medicine, other countries

Olopatadine in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All olopatadine products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

Austria · Olopatadin Micro Labs, Olopatadin Unimed Pharma
Bulgaria · Оловижън, Олопатадин Унимед Фарма
Cyprus · Alopatan, Olopatadine Rafarm
Czechia · Olopatadine Unimed Pharma, Olopatidine Olikla
Germany · Alltrevo, Olopatadin Actrevo
Denmark · Olopatadin Brown & Burk, Olopatadin Juta
Estonia · Olopatadine Unimed Pharma
Spain · Apadin, Olopatadina Abamed
United Kingdom (Northern Ireland) · Olopatadine Blumont Pharma, Olopatadine Brown & Burk Uk
Greece · Alopatan, Olopatadine Rafarm
Croatia · Olopatadin
Hungary · Olopatadine Unimed Pharma
Ireland · Olopatadine Brown & Burk
Iceland · Opatanol
Italy · Calmira®, Olonet
Liechtenstein · Opatanol
Lithuania · Olopatadine Unimed Pharma
Latvia · Olopatadine Unimed Pharma
Malta · Olopatadine Unimed Pharma
Norway · Olopatadine Sandoz, Opatanol
Poland · Oftahist, Olodon Free
Portugal · Olopatadina Stallpharma
Romania · Olopatadina Brown & Burk, Olopatadină Rompharm
Sweden · Olopatadin Evolan, Olopatadin Orifarm
Slovenia · Olopatadin Unimed Pharma
Slovakia · Olopatadine Olikla, Olopatadine Unimed Pharma

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/5d2b9865-a421-4734-883d-83645d188009
GET /v1/drugs/5d2b9865-a421-4734-883d-83645d188009?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oogdruppels, oplossing",
  "route": "Oculair gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h129960_smpc.pdf",
  "strength": null,
  "atc_label": "Olopatadine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg129960",
  "excipients": [
    "BENZALKONIUMCHLORIDE",
    "DINATRIUMWATERSTOFFOSFAAT 0-WATER (E 339)",
    "NATRIUMCHLORIDE",
    "NATRIUMHYDROXIDE (E 524)",
    "STIKSTOF (HEAD SPACE) (E 941)",
    "WATER VOOR INJECTIE",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "OLOPATADINEHYDROCHLORIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h129960.pdf",
  "authorised_at": "2025/03/10",
  "procedure_number": "SE/H/2247/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "129960",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about olopatadine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console